Mabion S.A. (WSE:MAB)
9.45
-0.05 (-0.53%)
Aug 14, 2025, 4:46 PM CET
Mabion Company Description
Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
It offers drug substance manufacturing, fill and finish, gene to vial: end-to-end development, process development, analytics, and cell line development and banking services.
The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
Mabion S.A.
Country | Poland |
Founded | 2007 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 213 |
CEO | Krzysztof Kaczmarczyk |
Contact Details
Address: Medical Biotechnology Scientific and Industrial Complex Konstantynów Lódzki, 95-050 Poland | |
Phone | 48 42 207 7890 |
Website | mabion.eu |
Stock Details
Ticker Symbol | MAB |
Exchange | Warsaw Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | PLN |
ISIN Number | PLMBION00016 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Krzysztof Kaczmarczyk | Chief Executive Officer and President of Management Board |
Grzegorz Grabowicz | Chief Financial Officer, Financial Director and Member of Management Board |
Adam Pietruszkiewicz | Chief Commercial Officer, Business Development Director and Member of Management Board |
Julita Balcerek M.D. | Member of the Management Board, Operations Director and Chief Operating Officer |
Pawel Pobiedzinski | Head of Logistics and Procurement |
Joanna Krolasik | Head of Microbiology Laboratory |